Characterization/bioinformatics-modeling of nanoparticle:complement interactions
纳米粒子的表征/生物信息学建模:补体相互作用
基本信息
- 批准号:8068114
- 负责人:
- 金额:$ 101.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-27 至 2013-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse effectsBiochemicalBioinformaticsBiologicalBiological AssayBiological ModelsBloodCellsCharacteristicsChargeClinicalComplementComplement ActivationComplement InactivatorsDevicesDiagnosisEncapsulatedFutureGoalsGuidelinesHumanImageIn VitroInstructionLipidsMedicalMembraneMethodsModelingMusNanostructuresPathway interactionsPharmaceutical PreparationsProcessProtocols documentationRegulationSafetySeriesStructure-Activity RelationshipSurfaceTestingTherapeuticTissuesWaterchemical propertycomplement systemdesignhuman studyhuman subjectin vivo Modelinstrumentmodels and simulationnanoparticlenext generationparticlesurfactanttool
项目摘要
DESCRIPTION (provided by applicant): Nanoparticles are emerging tools that will impact medical diagnosis and therapeutics with their capacity to target cells and tissues with imaging agents and/or drug payloads. The unique physical aspects of nanoparticles present new challenges for guidance and regulation. A wide variety of blood contact interactions may compromise intended nanoparticle activities and/or cause serious side effects. The simulation modeling of these and other critical biological interactions would provide a powerful predictive instrument that would offer a focus for the safety review of product candidates and allow the crafting of specific guidelines to be addressed by future applicants. It is known that certain lipid encapsulated nanoparticles activate the complement system, with the potential of severe tissue damage. We propose to develop a standard series of assays to characterize the interactions of complement with lipid encapsulated nanoparticles. The results will be applied to a bioinformatics-modeling system to design and assess next generation nanoparticles for clinical use. Our proposed specific efforts would provide a proof-of-concept approach to study a broad array of nanostructure:biological interactions that are currently difficult to predict prior to human study. To these ends we submit the following specific aims: (1) Develop standardized protocols using human in vitro and mouse In vivo models to characterize the capacity of lipid encapsulated nanoparticles to activate complement, to identify the activation pathways that facilitate the process, and to assess the impact of endogenous complement inhibitors on nanoparticle-dependent complement activation. (2) Vary lipid encapsulated nanoparticles to understand the influence of particle surface characteristics on complement activation. Manipulate surfactant components by utilizing natural and synthetically modified lipids to create a broad spectrum of biochemical presentations at, above, and below water-membrane interface that impart different charge or surface chemical properties. (3) Develop structure-activity relationships to predict complement activation.
PUBLIC HEALTH RELEVANCE: Nanoparticles are emerging tools that will impact medical diagnosis and therapeutics but present new challenges for product safety. The goal of this proposal is to construct a method for predicting likely harmful effects of nanoparticles prior to their testing in human subjects. Such a device would offer a focus for safety review of new candidate nanoparticle products and allow the crafting of specific guidelines to be addressed hv future nannnartinip riPRinns
描述(由申请人提供):纳米颗粒是新兴工具,将通过其利用显像剂和/或药物有效负载靶向细胞和组织的能力影响医学诊断和治疗。纳米颗粒独特的物理特性给指导和监管带来了新的挑战。各种各样的血液接触相互作用可能会损害预期的纳米颗粒活性和/或导致严重的副作用。这些和其他关键生物相互作用的模拟模型将提供强大的预测工具,为候选产品的安全审查提供重点,并允许制定未来申请人需要解决的具体指南。众所周知,某些脂质封装的纳米颗粒会激活补体系统,可能会造成严重的组织损伤。我们建议开发一系列标准测定法来表征补体与脂质封装纳米颗粒的相互作用。研究结果将应用于生物信息学建模系统,以设计和评估临床使用的下一代纳米颗粒。我们提出的具体努力将提供一种概念验证方法来研究广泛的纳米结构:目前在人类研究之前很难预测的生物相互作用。为此,我们提出以下具体目标:(1)使用人体体外和小鼠体内模型开发标准化方案,以表征脂质封装纳米颗粒激活补体的能力,确定促进该过程的激活途径,并评估内源性补体抑制剂对纳米颗粒依赖性补体激活的影响。 (2) 改变脂质封装的纳米颗粒,以了解颗粒表面特性对补体激活的影响。利用天然和合成改性的脂质来操纵表面活性剂成分,在水膜界面、上方和下方产生广泛的生化表现,赋予不同的电荷或表面化学性质。 (3) 建立结构-活性关系来预测补体激活。
公共健康相关性:纳米颗粒是新兴工具,将影响医学诊断和治疗,但对产品安全提出了新的挑战。该提案的目标是构建一种方法,在对人体进行测试之前预测纳米粒子可能产生的有害影响。这样的设备将为新候选纳米粒子产品的安全审查提供焦点,并允许制定具体指南以解决未来的nannnartinip riPRinns
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DENNIS EMIL HOURCADE其他文献
DENNIS EMIL HOURCADE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DENNIS EMIL HOURCADE', 18)}}的其他基金
Cellular Models of a Monogenic Small Vessel Disease of the Brain
脑单基因小血管疾病的细胞模型
- 批准号:
10307638 - 财政年份:2020
- 资助金额:
$ 101.16万 - 项目类别:
Analysis of Complement Activation and Regulation by Mass Cytometry
通过质谱流式细胞术分析补体激活和调节
- 批准号:
9235239 - 财政年份:2016
- 资助金额:
$ 101.16万 - 项目类别:
Characterization/bioinformatics-modeling of nanoparticle:complement interactions
纳米粒子的表征/生物信息学建模:补体相互作用
- 批准号:
8323416 - 财政年份:2010
- 资助金额:
$ 101.16万 - 项目类别:
Characterization/bioinformatics-modeling of nanoparticle:complement interactions
纳米粒子的表征/生物信息学建模:补体相互作用
- 批准号:
8150949 - 财政年份:2010
- 资助金额:
$ 101.16万 - 项目类别:
Complement Convertase: Assembly, Function and Regulation
补体转化酶:组装、功能和调节
- 批准号:
8070077 - 财政年份:2010
- 资助金额:
$ 101.16万 - 项目类别:
Complement Convertase: Assembly, Function and Regulation
补体转化酶:组装、功能和调节
- 批准号:
6616462 - 财政年份:2003
- 资助金额:
$ 101.16万 - 项目类别:
Complement Convertase: Assembly, Function and Regulation
补体转化酶:组装、功能和调节
- 批准号:
7800882 - 财政年份:2003
- 资助金额:
$ 101.16万 - 项目类别:
COMPLEMENT CONVERTASE: ASSEMBLY, FUNCTION AND REGULATION
补充转化酶:组装、功能和调节
- 批准号:
8437634 - 财政年份:2003
- 资助金额:
$ 101.16万 - 项目类别:
COMPLEMENT CONVERTASE: ASSEMBLY, FUNCTION AND REGULATION
补充转化酶:组装、功能和调节
- 批准号:
8897952 - 财政年份:2003
- 资助金额:
$ 101.16万 - 项目类别:
Complement Convertase: Assembly, Function and Regulation
补体转化酶:组装、功能和调节
- 批准号:
8055493 - 财政年份:2003
- 资助金额:
$ 101.16万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 101.16万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 101.16万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 101.16万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 101.16万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 101.16万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 101.16万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 101.16万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 101.16万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 101.16万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 101.16万 - 项目类别:
Discovery Grants Program - Individual